Does dabigatran reduce the risk of osteoporotic fractures compared to warfarin in adults with nonvalvular atrial fibrillation?
Dabigatran is associated with a lower risk of osteoporotic fractures compared to warfarin in patients with nonvalvular atrial fibrillation.
Among adults with NVAF receiving anticoagulation, the use of dabigatran compared with warfarin was associated with a lower risk of osteoporotic fracture. Additional study, perhaps including randomized clinical trials, may be warranted to further understand the relationship between use of dabigatran vs warfarin and risk of fracture.
Lau et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: